IL1B and lung carcinoma: In addition, the lung cancer risk was associated with higher levels of IL-1β and IFN-γ than the LOD value (HR [95% CI]: 1.61 [1.11–2.32], 1.85 [1.26–2.72], respectively) (Table 3).